Company Filing History:
1 out of 4 
1 out of 18 
1 out of 6 Years Active: 1996-2000
Title: Ronald Hans Plasterk: Innovator in Genetic Engineering
Introduction
Ronald Hans Plasterk is a notable inventor based in Bussum, Netherlands. He has made significant contributions to the field of genetic engineering, holding two patents that showcase his innovative approach to biotechnology.
Latest Patents
Plasterk's latest patents include "Vectors and methods for providing cells with additional nucleic acid." This invention provides novel elements for improving genetic engineering techniques for producing recombinant nucleic acid molecules and/or recombinant cells. The elements are capable of integrating desired nucleic acid material into other nucleic acid materials, specifically into the genome of a host cell. These elements are derived from or based on transposons, particularly from the Tc/Mariner superfamily. The essential elements of Tc1 enable the excision and pasting of the desired nucleic acid material, along with the relevant transposase activity in cis or in trans. Another significant patent is "Viral integrase inhibiting peptides." This invention provides viral integrase inhibiting peptides with a specific structure, where the amino acids can be either D-amino acids or L-amino acids. The invention also includes a pharmaceutical composition comprising a viral integrase inhibiting peptide and methods for using it to reduce or inhibit viral integrase activity in a cell.
Career Highlights
Throughout his career, Plasterk has worked with esteemed organizations such as the Netherlands Cancer Institute and Introgene B.V. His work has significantly impacted the field of genetic research and biotechnology.
Collaborations
Plasterk has collaborated with notable individuals in his field, including Domenico Valerio and Govert Johan Schouten. These collaborations have further enhanced his contributions to genetic engineering.
Conclusion
Ronald Hans Plasterk's innovative work in genetic engineering has led to significant advancements in biotechnology. His patents reflect a deep understanding of genetic manipulation and its potential applications in medicine.